Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

The Residency Report

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Videos

At ARVO 2025, in Salt Lake City, Utah, Viha Vig, talked about her poster presentation investigating the relationship between ocular and systemic mitochondrial diseases and dementia

ARVO 2025: Association between ocular and systemic mitochondrial diseases and dementia

Articles

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal disease treatment and reduced injection burden.

Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases

Financing will fund phase 1b trials evaluating its lead candidate, THN391, for the treatment of Alzheimer’s Disease and Diabetic Macular Edema (DME).

Therini Bio raises $39 million in a Series A extension financing

SYL1801 is an investigational siRNA therapy administered via eye drops, rather than intravitreal injection, to treat nAMD.

Sylentis releases topline results from phase 2a of SYL1801

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Improving Vision with Innovative Intraocular Lenses for Cataract Treatment

Neda Shamie, MD, discusses two patient cases and highlights the factors to consider when choosing intraocular lenses for cataract surgery. She emphasized the importance of considering patient factors and needs in selecting the right lens option.

Neda Shamie, MD, presents a case of a 65-year-old college professor with monovision who sought freedom from glasses following cataract surgery.

Patient Case #1: Choosing a Cataract Lens for a Patient with Monovision

Neda Shamie, MD, discusses the factors to consider when selecting cataract lenses for patients with monovision and emphasized how light adjustable lenses offer flexibility in correcting vision to the desired target after surgery.

Patient Case #1: Impressions and Takeaways

Neda Shamie, MD, reviews the case of a 56-year-old photographer who desires excellent midrange and distance vision with high contrast sensitivity.

Patient Case #2: Choosing a Cataract Lens for a Patient Needing Excellent Midrange and Distance Vision

Neda Shamie, MD, explains how her practice has established procedures for incorporating light adjustable lenses into their cataract surgery workflow.

Implementing the Light Adjustable Lens in Practice

Patient Case #1: Choosing a Cataract Lens for a Patient with Monovision

EP: 1.Patient Case #1: Choosing a Cataract Lens for a Patient with Monovision

EP: 2.Patient Case #1: Impressions and Takeaways

EP: 3.Patient Case #2: Choosing a Cataract Lens for a Patient Needing Excellent Midrange and Distance Vision

EP: 4.Implementing the Light Adjustable Lens in Practice

Newsletter